Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Zena Khaznadar"'
1
Akademický článek
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Autor: Delphine Rea, Guylaine Henry, Zena Khaznadar, Gabriel Etienne, François Guilhot, Franck Nicolini, Joelle Guilhot, Philippe Rousselot, Françoise Huguet, Laurence Legros, Martine Gardembas, Viviane Dubruille, Agnès Guerci-Bresler, Aude Charbonnier, Frédéric Maloisel, Jean-Christophe Ianotto, Bruno Villemagne, François-Xavier Mahon, Hélène Moins-Teisserenc, Nicolas Dulphy, Antoine Toubert
Publikováno v: Haematologica, Vol 102, Iss 8 (2017)
Despite persistence of leukemic stem cells, patients with chronic myeloid leukemia who achieve and maintain deep molecular responses may successfully stop the tyrosine kinase inhibitor imatinib. However, questions remain unanswered regarding the biol
Externí odkaz: https://doaj.org/article/67115956ca4149a996eec65e65a9b9c2
Zobrazit plný text záznamu
2
Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer
Autor: Marion David, Marie Degremont, Agnès Loeb, Zena Khaznadar, Marianne Leheurteur, Anne Perdrix, Frédéric Di Fiore, Mathilde Saint-Ghislain, Florian Clatot
Publikováno v: Reproductive BioMedicine
Reproductive BioMedicine Online, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, Elsevier, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
The impact of chemotherapy on fertility appears to be of essential importance for the youngest cancer survivors. The aim of this study was to assess plasma anti-Mullerian hormone (AMH) evolution, using an automated sensitive AMH immunoassay in women
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8f3c6eef0e67acd267471da0a1f7e0
https://doi.org/10.1016/j.rbmo.2017.06.005
Zobrazit plný text záznamu
3
Skin donors and human skin allografts: evaluation of an 11-year practice and discard in a referral tissue bank
Autor: Jean-Claude Gourevitch, Sonia Gaucher, Zena Khaznadar, Mohamed Jarraya
Publikováno v: Cell and Tissue Banking. 17:11-19
The Saint Louis hospital tissue bank provides skin allografts to pediatric and adult burn units in the Paris area. The aim of this study was to analyze our activity during the last 11 years focusing on the reasons for skin discard. Skin is procured s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::815020115ee0f74961d88a559391a749
https://doi.org/10.1007/s10561-015-9528-3
Zobrazit plný text záznamu
4
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Autor: Antoine Toubert, Agnès Guerci-Bresler, Hélène Moins-Teisserenc, Gabriel Etienne, Delphine Rea, Françoise Huguet, Laurence Legros, François Guilhot, Frédéric Maloisel, Zena Khaznadar, Joelle Guilhot, Martine Gardembas, Philippe Rousselot, Francois-Xavier Mahon, Bruno Villemagne, Jean-Christophe Ianotto, Franck E. Nicolini, Nicolas Dulphy, Viviane Dubruille, Aude Charbonnier, Guylaine Henry
Publikováno v: Haematologica
Haematologica, Ferrata Storti Foundation, 2017, 102 (8), pp.1368-1377. ⟨10.3324/haematol.2017.165001⟩
Despite persistence of leukemic stem cells, patients with chronic myeloid leukemia who achieve and maintain deep molecular responses may successfully stop the tyrosine kinase inhibitor imatinib. However, questions remain unanswered regarding the biol
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5cdd784405d334de4fb792656ae9193
https://hal.archives-ouvertes.fr/hal-02043232/document
Zobrazit plný text záznamu
5
Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence
Autor: Hocine Rachid Hocine, Ryad Tamouza, Noemie Dam, Luis R. Borlado, Johan Siewiera, Laura Lauden, Nabila Jabrane-Ferrat, Zena Khaznadar, Dominique Charron, Wahid Boukouaci, Reem Al-Daccak
Publikováno v: Cardiovascular Research
Cardiovascular Research, Oxford University Press (OUP), 2014, 104 (2), pp.290-302. ⟨10.1093/cvr/cvu208⟩
Aims Allogeneic human cardiac-derived stem/progenitor cells (hCPC) are promising candidates for cardiac repair. They interact with T cells, major effectors of the adaptive immune response, inducing ‘paracrine’ anti-inflammatory effects that could
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7b598779085c772128a24e4f858e89
https://doi.org/10.1093/cvr/cvu208
Zobrazit plný text záznamu
6
Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse
Autor: Emmanuel Raffoux, Antoine Toubert, Hervé Dombret, Zena Khaznadar, Niclas Setterblad, Guylaine Henry, Sophie Agaugué, Nicolas Boissel, Nicolas Dulphy
Publikováno v: European Journal of Immunology. 44:3068-3080
Acute myeloid leukemia (AML) cells are killed by allogeneic NK cells. However, autologous NK cells from AML patients express decreased levels of activating receptors, and show reduced cytotoxicity. Here, we investigated how interactions between NK an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7dff9876e13e36d4667ac0b06a868203
https://doi.org/10.1002/eji.201444500
Zobrazit plný text záznamu
7
At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity
Autor: Catherine Thieblemont, Nicolas Dulphy, Antoine Toubert, Guylaine Henry, Daniela Geromin, Zena Khaznadar, Josette Brière, Anne Danielou-Lazareth, Ryad Tamouza, Jean-Michel Cayuela
Publikováno v: European Journal of Immunology. 43:1383-1388
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma in adults. It is generally treated by a combination of chemotherapy and CD20-specific mAbs, such as rituximab, which act, at least partially, by activating ant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::783cab0fb510ce41bb326538cc3f31d2
https://doi.org/10.1002/eji.201242733
Zobrazit plný text záznamu
8
Underground Adaptation to a hostile environment: Acute Myeloid Leukemia vs. Natural Killer cells
Autor: Anne-Sophie Chretien, Anne Caignard, Nicolas Dulphy, Arash Nanbakhsh, Daniel Olive, Salem Chouaib, Cyril Fauriat, Zena Khaznadar, Antoine Toubert
Publikováno v: Frontiers in Immunology, Vol 7 (2016)
Frontiers in Immunology
Acute myeloid leukemia (AML) is a heterogeneous group of malignancies which incidence increases with age. The disease affects the differentiation of hematopoietic stem or precursor cells in the bone marrow and can be related to abnormal cytogenetic a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eea03fe9c518d98a856ac7455c5e3868
http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00094/full
Zobrazit plný text záznamu
9
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion
Autor: Hervé Dombret, Daniela Geromin, Joël Lachuer, Sophie Agaugué, Nicolas Dulphy, Zena Khaznadar, Emmanuel Raffoux, Marguerite Vignon, Guylaine Henry, Claude Preudhomme, Sylvie Castaigne, François Sigaux, Cécile Pautas, Antoine Toubert, Nicolas Boissel, Jean-Michel Cayuela, Meyling Cheok
Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 195(6)
Acute myeloid leukemia (AML) is a heterogeneous group of malignancies that may be sensitive to the NK cell antitumor response. However, NK cells are frequently defective in AML. In this study, we found in an exploratory cohort (n = 46) that NK cell s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54cf72e01bb8a6c3f1565ac89b18b9e
https://pubmed.ncbi.nlm.nih.gov/26246143
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje